<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="review-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mol Brain</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol Brain</journal-id>
<journal-title-group>
<journal-title>Molecular Brain</journal-title>
</journal-title-group>
<issn pub-type="epub">1756-6606</issn>
<publisher>
<publisher-name>BioMed Central</publisher-name>
<publisher-loc>London</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29301575</article-id>
<article-id pub-id-type="pmc">5753567</article-id>
<article-id pub-id-type="publisher-id">343</article-id>
<article-id pub-id-type="doi">10.1186/s13041-017-0343-6</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Review</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Warburg effect hypothesis in autism Spectrum disorders</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Vallée</surname>
<given-names>Alexandre</given-names>
</name>
<address>
<email>alexandre.g.vallee@gmail.com</email>
</address>
<xref ref-type="aff" rid="Aff1">1</xref>
<xref ref-type="aff" rid="Aff2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Vallée</surname>
<given-names>Jean-Noël</given-names>
</name>
<address>
<email>valleejn@gmail.com</email>
</address>
<xref ref-type="aff" rid="Aff2">2</xref>
<xref ref-type="aff" rid="Aff3">3</xref>
</contrib>
<aff id="Aff1"><label>1</label>Laboratoire de Mathématiques et Applications (LMA), UMR CNRS 7348, CHU Poitiers, University of Poitiers, Poitiers, France </aff>
<aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 2160 6368</institution-id><institution-id institution-id-type="GRID">grid.11166.31</institution-id><institution>Laboratoire de Mathématiques et Applications (LMA), UMR CNRS 7348, </institution><institution>University of Poitiers, </institution></institution-wrap>11 Boulevard Marie et Pierre Curie, Poitiers, France </aff>
<aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ISNI">0000 0001 0789 1385</institution-id><institution-id institution-id-type="GRID">grid.11162.35</institution-id><institution>CHU Amiens Picardie, </institution><institution>Université Picardie Jules Verne (UPJV), </institution></institution-wrap>Amiens, France </aff>
</contrib-group>
<pub-date pub-type="epub">
<day>4</day>
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>4</day>
<month>1</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="collection">
<year>2018</year>
</pub-date>
<volume>11</volume>
<elocation-id>1</elocation-id>
<history>
<date date-type="received">
<day>18</day>
<month>10</month>
<year>2017</year>
</date>
<date date-type="accepted">
<day>13</day>
<month>12</month>
<year>2017</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author(s). 2018</copyright-statement>
<license license-type="OpenAccess">
<license-p><bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
</license>
</permissions>
<abstract id="Abs1">
<p id="Par1">Autism spectrum disorder (ASD) is a neurodevelopmental disease which is characterized by a deficit in social interactions and communication with repetitive and restrictive behavior. In altered cells, metabolic enzymes are modified by the dysregulation of the canonical WNT/β-catenin pathway. In ASD, the canonical WNT/β-catenin pathway is upregulated. We focus this review on the hypothesis of Warburg effect stimulated by the overexpression of the canonical WNT/β-catenin pathway in ASD. Upregulation of WNT/β-catenin pathway induces aerobic glycolysis, named Warburg effect, through activation of glucose transporter (Glut), pyruvate kinase M2 (PKM2), pyruvate dehydrogenase kinase 1(PDK1), monocarboxylate lactate transporter 1 (MCT-1), lactate dehydrogenase kinase-A (LDH-A) and inactivation of pyruvate dehydrogenase complex (PDH). The aerobic glycolysis consists to a supply of a large part of glucose into lactate regardless of oxygen. Aerobic glycolysis is less efficient in terms of ATP production than oxidative phosphorylation because of the shunt of the TCA cycle. Dysregulation of energetic metabolism might promote cell deregulation and progression of ASD. Warburg effect regulation could be an attractive target for developing therapeutic interventions in ASD.</p>
</abstract>
<kwd-group xml:lang="en">
<title>Keywords</title>
<kwd>WNT/β-catenin pathway</kwd>
<kwd>Aerobic glycolysis</kwd>
<kwd>Warburg effect</kwd>
<kwd>Lactate</kwd>
<kwd>Autism spectrum disorders</kwd>
<kwd>LDH-a</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta>
<meta-name>issue-copyright-statement</meta-name>
<meta-value>© The Author(s) 2018</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="Sec1">
<title>Background</title>
<p id="Par22">Autism spectrum disorders (ASD) is a neurodevelopmental disease which is characterized by a deficit in social interactions and communication with repetitive and restrictive behaviors [<xref ref-type="bibr" rid="CR1">1</xref>], poor eye contact [<xref ref-type="bibr" rid="CR2">2</xref>] and disruption of cognitive and motor development [<xref ref-type="bibr" rid="CR3">3</xref>]. ASD is mainly diagnosed within the first three years of life. Early diagnosis is critical for better prognosis and therapeutic care [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. 10% of ASD cases are associated with a “genetic syndromic ASD” and the other cases, as “idiopathic ASD” and “primary ASD”, have no clearly known causes. Several genetic factor and environmental effects may contribute to the heterogeneity etiologic of this disease [<xref ref-type="bibr" rid="CR6">6</xref>]. However, the etiology of ASD remains unknown.</p>
<p id="Par23">Dysregulation of the core neurodevelopmental pathways is associated with the clinical presentation of ASD, and one of the major pathways involved in developmental cognitive disorders is the canonical WNT/β-catenin pathway [<xref ref-type="bibr" rid="CR7">7</xref>]. Several genetic mutations observed in ASD are linked with the deregulation of the canonical WNT/β-catenin pathway by interactions between chromodomain helicase DNA binding protein 8 (CDH8) and CTNNB1 (β-catenin) [<xref ref-type="bibr" rid="CR8">8</xref>]. Canonical WNT/β-catenin pathway has a critical role in the development of the central nervous system (CNS), and is over-expressed in ASD [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR9">9</xref>, <xref ref-type="bibr" rid="CR10">10</xref>].</p>
<p id="Par24">Metabolic enzymes are modified by the dysregulation of the canonical WNT/β-catenin pathway. Upregulation of WNT/β-catenin signaling leads to activation of pyruvate dehydrogenase kinase-1 (PDK-1), which decreases the activity of the pyruvate dehydrogenase complex (PDH). Upregulation of WNT/β-catenin signaling also activates monocarboxylate lactate transporter-1 (MCT-1) [<xref ref-type="bibr" rid="CR11">11</xref>]. This do not allow the conversion of pyruvate into acetyl-coenzyme A (acetyl-CoA) in mitochondria and its entry into the tricarboxylic acid (TCA) cycle. At this stage, cytosolic pyruvate is converted into lactate for the major party. This phenomenon is called Warburg effect or aerobic glycolysis despite the availability of oxygen [<xref ref-type="bibr" rid="CR12">12</xref>].</p>
<p id="Par25">Mitochondrial deregulation is one of the main metabolic abnormalities observed in ASD physiopathology [<xref ref-type="bibr" rid="CR13">13</xref>–<xref ref-type="bibr" rid="CR17">17</xref>]. Several studies have shown a significant increase in lactate dehydrogenase kinase A (LDH-A) expression and pyruvate levels [<xref ref-type="bibr" rid="CR18">18</xref>] with an increased lactate/pyruvate ratio [<xref ref-type="bibr" rid="CR19">19</xref>], and elevated levels of lactate in ASD patients [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR21">21</xref>].</p>
<p id="Par26">There is some common denominator between these metabolic abnormalities, which strongly suggests the reprogramming of cellular energy metabolism with increase lactate production induced by over-expressed canonical WNT/β-catenin pathway in ASD.</p>
<p id="Par27">We focus this review on the hypothesis of Warburg effect induced by over-expressed canonical WNT/β-catenin pathway in ASD.</p>
<sec id="Sec2">
<title>Canonical WNT/β-catenin pathway</title>
<p id="Par28">Wingless and integration site (called WNT) pathway is a cascade of several signaling implicated in development, growth, and metabolism [<xref ref-type="bibr" rid="CR22">22</xref>]. WNT signaling is composed by secreted lipid-modified glycoproteins [<xref ref-type="bibr" rid="CR23">23</xref>]. WNT/β-catenin pathway is involved in numerous mechanisms such as patterning, development of synapses in the CNS [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR25">25</xref>], synaptogenesis [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR27">27</xref>] and the control of synaptic formation [<xref ref-type="bibr" rid="CR24">24</xref>, <xref ref-type="bibr" rid="CR28">28</xref>].</p>
<p id="Par29">Dysregulation of the canonical WNT/β-catenin pathway is observed in numerous diseases [<xref ref-type="bibr" rid="CR29">29</xref>], such as cancers, as gliomas [<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>] and colon cancer [<xref ref-type="bibr" rid="CR32">32</xref>], and neurodegenerative diseases as Alzheimer’s disease [<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR34">34</xref>], age macular degeneration [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>], amyotrophic lateral sclerosis [<xref ref-type="bibr" rid="CR37">37</xref>] and multiple sclerosis [<xref ref-type="bibr" rid="CR38">38</xref>] (Table <xref ref-type="table" rid="Tab1">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>Canonical WNT/β-catenin pathway dysregulation</p></caption><table frame="hsides" rules="groups"><thead><tr><th>WNT/β-catenin pathway</th><th>Pathologies</th><th>References</th></tr></thead><tbody><tr><td rowspan="12">Increase</td><td>Age-macular degeneration</td><td>[<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>]</td></tr><tr><td>Aging</td><td>[<xref ref-type="bibr" rid="CR113">113</xref>]</td></tr><tr><td>Amyotrophic lateral sclerosis</td><td>[<xref ref-type="bibr" rid="CR37">37</xref>]</td></tr><tr><td>Atherosclerosis</td><td>[<xref ref-type="bibr" rid="CR114">114</xref>]</td></tr><tr><td>Cancers</td><td>[<xref ref-type="bibr" rid="CR97">97</xref>]</td></tr><tr><td>Colon cancer</td><td>[<xref ref-type="bibr" rid="CR115">115</xref>]</td></tr><tr><td>Diabetes 2</td><td>[<xref ref-type="bibr" rid="CR32">32</xref>]</td></tr><tr><td>Fibrosis</td><td>[<xref ref-type="bibr" rid="CR116">116</xref>, <xref ref-type="bibr" rid="CR117">117</xref>]</td></tr><tr><td>Gliomas</td><td>[<xref ref-type="bibr" rid="CR30">30</xref>, <xref ref-type="bibr" rid="CR31">31</xref>]</td></tr><tr><td>Huntington’s disease</td><td>[<xref ref-type="bibr" rid="CR118">118</xref>]</td></tr><tr><td>Multiple sclerosis</td><td>[<xref ref-type="bibr" rid="CR34">34</xref>]</td></tr><tr><td>Radiation-induced fibrosis</td><td>[<xref ref-type="bibr" rid="CR119">119</xref>]</td></tr><tr><td rowspan="5">Decrease</td><td>Alzheimer’s disease</td><td>[<xref ref-type="bibr" rid="CR33">33</xref>, <xref ref-type="bibr" rid="CR34">34</xref>, <xref ref-type="bibr" rid="CR120">120</xref>]</td></tr><tr><td>Arrhythmogenic right ventricular cardiomyopathy</td><td>[<xref ref-type="bibr" rid="CR121">121</xref>]</td></tr><tr><td>Bipolar disorder</td><td>[<xref ref-type="bibr" rid="CR122">122</xref>]</td></tr><tr><td>Osteoporosis</td><td>[<xref ref-type="bibr" rid="CR123">123</xref>]</td></tr><tr><td>Parkinson’s disease</td><td>[<xref ref-type="bibr" rid="CR124">124</xref>]</td></tr></tbody></table></table-wrap></p>
<p id="Par30">WNT family genes are 19 members which are classified as canonical and non-canonical WNT pathway. Canonical WNT ligands are seven, as WNT1, WNT2, WNT3, WNT8a, WNT8b, WNT10a and WNT10b). They are activators of the WNT/β-catenin pathway. Canonical WNT ligands are secreted by neurons and immune cells in the CNS [<xref ref-type="bibr" rid="CR39">39</xref>]. The non-canonical WNT pathway is independent to β-catenin signaling and is separated into the planar cell planar cell polarity pathway and the WNT/Ca<sup>2+</sup> pathway.</p>
<p id="Par31">WNT extracellular ligands bind low density lipoprotein receptor-related protein 5 and 6 (LRP 5/6), Frizzled (FZD) receptors, and then disheveled (DSH), resulting in β-catenin accumulation and nuclear translocation. Thus, N-nuclear β-catenin bind T-cell factor/lymphoid enhancer factor (TCF/LEF) [<xref ref-type="bibr" rid="CR40">40</xref>]. The complex formed TCF/LEF–nuclear β-catenin leads to the stimulation and the transcription of several WNT target genes (c-Myc, cyclin D1) [<xref ref-type="bibr" rid="CR41">41</xref>].</p>
<p id="Par32">The absence of binding between membrane receptors and WNT extracellular ligands characterizes the downregulation of WNT/β-catenin pathway. The β-catenin complex destruction is formed by adenomatous polyposis coli (APC), AXIN and glycogen synthase kinase-3β (GSK-3 β). This complex binds β-catenin to degrade it into the proteasome [<xref ref-type="bibr" rid="CR42">42</xref>]. Activated GSK-3β downregulates β-catenin accumulation and its nuclear translocation [<xref ref-type="bibr" rid="CR42">42</xref>, <xref ref-type="bibr" rid="CR43">43</xref>].</p>
<sec id="Sec3">
<title>WNT/β-catenin pathway and PI3K/Akt pathway</title>
<p id="Par33">Phosphatidylinositol 3-kinase/serine/threonine kinase (protein kinase B)/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway is implicated in proliferation, growth, protein synthesis and metabolism [<xref ref-type="bibr" rid="CR44">44</xref>–<xref ref-type="bibr" rid="CR47">47</xref>]. WNT/β-catenin pathway, through the inhibition GSK-3β activity [<xref ref-type="bibr" rid="CR48">48</xref>], is considered as one of the main activator of PI3K/Akt/mTOR pathway [<xref ref-type="bibr" rid="CR49">49</xref>]. GSK-3β, a major inhibitor of the WNT ligands [<xref ref-type="bibr" rid="CR50">50</xref>], is a specific intracellular serine-threonine kinase which regulates numerous pathophysiological pathways [<xref ref-type="bibr" rid="CR51">51</xref>–<xref ref-type="bibr" rid="CR53">53</xref>]. PI3K/Akt pathway decreases the activity of GSK-3β in adipocyte differentiation [<xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR55">55</xref>]. In addition, decrease of β-catenin levels downregulates the expression of PI3K/Akt/mTOR pathway [<xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR57">57</xref>].</p>
</sec>
<sec id="Sec4">
<title>Canonical WNT/β-catenin and PI3K/Akt pathways in ASD</title>
<p id="Par34">Several studies have shown the major role of activated WNT/β-catenin pathway in ASD [<xref ref-type="bibr" rid="CR58">58</xref>–<xref ref-type="bibr" rid="CR60">60</xref>]. Numerous genetic components are correlated with ASD development such as WNT2 ligand [<xref ref-type="bibr" rid="CR61">61</xref>], hepatocyte growth factor receptor (MET) which is a WNT target gene [<xref ref-type="bibr" rid="CR62">62</xref>, <xref ref-type="bibr" rid="CR63">63</xref>], and chromo-helicase domain protein 8 (CHD8) and DYRK1A which can both modulate WNT/β-catenin pathway [<xref ref-type="bibr" rid="CR64">64</xref>–<xref ref-type="bibr" rid="CR66">66</xref>].</p>
<p id="Par35">Several studies has shown a main role of numerous compounds of the WNT/β-catenin pathway in ASD, such as WNT1 [<xref ref-type="bibr" rid="CR67">67</xref>], WNT2 [<xref ref-type="bibr" rid="CR61">61</xref>], WNT3 [<xref ref-type="bibr" rid="CR68">68</xref>], WNT7A [<xref ref-type="bibr" rid="CR69">69</xref>], APC [<xref ref-type="bibr" rid="CR70">70</xref>–<xref ref-type="bibr" rid="CR72">72</xref>], β-catenin [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR73">73</xref>], TCF4 [<xref ref-type="bibr" rid="CR74">74</xref>, <xref ref-type="bibr" rid="CR75">75</xref>] and TCF7 [<xref ref-type="bibr" rid="CR76">76</xref>].</p>
<p id="Par36">The knockout of the gene encoding phosphatase and tensin homolog protein (PTEN), a cytoplasmic protein suppressor of WNT/β-catenin pathway, has been identified as a high-risk ASD susceptibility gene [<xref ref-type="bibr" rid="CR77">77</xref>–<xref ref-type="bibr" rid="CR80">80</xref>]. PTEN is also a negative regulator of PI3K/Akt pathway [<xref ref-type="bibr" rid="CR81">81</xref>] and deletion of PTEN expression leads to stimulate proliferation and migration through the activation of mTOR activity [<xref ref-type="bibr" rid="CR82">82</xref>]. Knockout of PTEN in Purkinje cells impairs social relation, behavior and deficits in motor learning [<xref ref-type="bibr" rid="CR83">83</xref>, <xref ref-type="bibr" rid="CR84">84</xref>]. PTEN and β-catenin regulate each other leading to normal growth of the brain [<xref ref-type="bibr" rid="CR85">85</xref>].</p>
</sec>
<sec id="Sec5">
<title>Valproate and ASD</title>
<p id="Par37">Valproate (or Valproic acid, VPA) is an anti-convulsing agent discovered in 1963 and used for treatment of bipolar disorders or migraine [<xref ref-type="bibr" rid="CR86">86</xref>, <xref ref-type="bibr" rid="CR87">87</xref>]. VPA decreases GSK-3β activity and then stimulates WNT/β-catenin pathway [<xref ref-type="bibr" rid="CR88">88</xref>–<xref ref-type="bibr" rid="CR90">90</xref>].</p>
<p id="Par38">In neural stem cells of the CNS, VPA can increase WNT3a expression and β-catenin accumulation [<xref ref-type="bibr" rid="CR90">90</xref>]. In rat models, treatment with VPA activates WNT/β-catenin pathway and inhibits GSK-3β activity, which stimulates PI3K/Akt/mTOR pathway [<xref ref-type="bibr" rid="CR89">89</xref>, <xref ref-type="bibr" rid="CR91">91</xref>]. VPA increases the risk of ASD in pregnant woman during prenatal development through the stimulation of WNT/β-catenin pathway [<xref ref-type="bibr" rid="CR92">92</xref>].</p>
</sec>
</sec>
<sec id="Sec6">
<title>Warburg effect</title>
<p id="Par39">The Warburg effect (also named aerobic glycolysis) consists to a conversion of a large part of glucose into lactate regardless of oxygen [<xref ref-type="bibr" rid="CR12">12</xref>]. Activated PDK1 phosphorylates the PDH in order to stop the conversion of pyruvate into acetyl-coA in mitochondria [<xref ref-type="bibr" rid="CR93">93</xref>]. This conversion is proportionally diminished with a consequent reduction of acetyl-CoA entering the tricarboxylic acid (TCA) cycle. Then, cytosolic pyruvate being towards the formation of lactate which is then expelled from the cell by the upregulation of both lactate dehydrogenase A (LDH-A) and MCT-1. The higher production of lactate through this action favors anabolic production of biomass, and nucleotide synthesis [<xref ref-type="bibr" rid="CR94">94</xref>]. However, the oxidative phosphorylation stays more efficient in terms of ATP production than aerobic glycolysis because of the shunt of the TCA cycle. PDK transcription is also regulated by insulin, glucocorticoids, thyroid hormone and fatty acids [<xref ref-type="bibr" rid="CR95">95</xref>] which allow the metabolic flexibility [<xref ref-type="bibr" rid="CR94">94</xref>].</p>
<sec id="Sec7">
<title>Warburg effect activation through canonical WNT/β-catenin pathway stimulation (Fig. <xref ref-type="fig" rid="Fig1">1</xref>)</title>
<p id="Par40">Several studies have shown that aerobic glycolysis is induced by overactivation of the WNT/β-catenin pathway through a direct activation of PDK1 and MCT-1 [<xref ref-type="bibr" rid="CR31">31</xref>, <xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR96">96</xref>, <xref ref-type="bibr" rid="CR97">97</xref>]. β-catenin activation induces the expression of PI3K/Akt signaling [<xref ref-type="bibr" rid="CR56">56</xref>, <xref ref-type="bibr" rid="CR57">57</xref>].<fig id="Fig1"><label>Fig. 1</label><caption><p>Relation between activated WNT/β-catenin pathway and Warburg effect in ASD. Mutations in ASD lead to activate the presence of WNT ligands. Then, WNT binds both Frizzled and LRP 5/6 receptors to phosphorylate the AXIN/APC/GSK-3β complex. Thus, β-catenin phosphorylation is stopped and this inhibits its degradation into the proteasome. β-catenin accumulates in the cytosol and translocates to the nucleus to bind the complex TCF/LEF co transcription factors. WNT target gene transcription is activated by nuclear β-catenin (PDK, c-Myc, cyclin D1, MCT-1). Glucose also activates the WNT signaling. MCT-1 favors lactate expulsion out of the cell. WNT/β-catenin pathway activates tyrosine kinase receptors (TKRs) activity. Activated PI3K/Akt pathway stimulates glucose metabolism. Akt-transformed cells protect against reactive oxygen species stress (ROS) by inducing HIF-1α, which suppresses glucose entry into the TCA cycle. Stimulation of HIF-1α activity activates the expression of the glycolytic enzymes (GLUT, HK, PKM2, LDH-A). Aerobic glycolysis is observed with the increase of lactate production and the decrease of mitochondrial respiration. HIF-1α induced PDK phosphorylates PDH, which resulting in cytosolic pyruvate being shunted into lactate by inducing LDH-A activation. PDK inhibits the PDH complex into the mitochondria, thus pyruvate cannot be fully converted into acetyl-CoA and enter the TCA cycle. c-Myc and cyclin D1 also stimulates LDH-A activity which converts cytosolic pyruvate into lactate. Activated PKM2 translocates to the nucleus to bind β-catenin and then to induce the expression of c-Myc</p></caption><graphic id="MO1" xlink:href="13041_2017_343_Fig1_HTML"></graphic></fig></p>
<p id="Par41">Increase rate of glucose metabolism is associated with the overactivation of PI3K/Akt pathway [<xref ref-type="bibr" rid="CR98">98</xref>]. Activation of PI3K/Akt pathway stimulates HIF-1α (hypoxia-inducible factor 1-α) [<xref ref-type="bibr" rid="CR99">99</xref>], which induces stimulation of glycolytic enzymes such as Glut, LDH-A, PDK1 and PKM2 [<xref ref-type="bibr" rid="CR99">99</xref>, <xref ref-type="bibr" rid="CR100">100</xref>].</p>
<p id="Par42">Glut-1 and Glut-3 are mainly important for the insulin-sensitive homeostasis of glucose transport [<xref ref-type="bibr" rid="CR101">101</xref>]. Then, the conversion of phosphoenolpyruvate (PEP) and ADP into pyruvate is the final step in glycolysis after glucose entered the cell. The enzyme pyruvate kinase (PK) catalyzes this reaction. PK have four isoforms: PKM1, PKM2, PKL, and PKR. The dimeric form of PKM2 has low affinity with PEP [<xref ref-type="bibr" rid="CR102">102</xref>]. Under high glucose concentration, PKM2 is translocated to the nucleus through the action of peptidyl-prolyl isomerase 1 (Pin1) [<xref ref-type="bibr" rid="CR103">103</xref>], which reduces its activity and targets PKM2 toward lysosome-dependent degradation [<xref ref-type="bibr" rid="CR104">104</xref>]. Nuclear PKM2 binds nuclear β-catenin and then induces c-Myc-mediated expression of glycolytic enzymes including Glut, LDH-A, PDK1, and PKM2 [<xref ref-type="bibr" rid="CR105">105</xref>].</p>
<p id="Par43">Activated c-Myc also activates glutaminolysis and tends to nucleotide synthesis [<xref ref-type="bibr" rid="CR106">106</xref>] by activating HIF-1α which controls PDK1 [<xref ref-type="bibr" rid="CR107">107</xref>]. A minor part of the pyruvate is converted into acetyl-CoA which enters the TCA cycle and become citrate for promoting protein and lipid synthesis.</p>
</sec>
<sec id="Sec8">
<title>Lactate production in ASD</title>
<p id="Par44">Up to now, few studies have described the expression of the different glycolytic enzymes in ASD. However, several studies have shown elevated lactate levels in ASD patients [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR18">18</xref>–<xref ref-type="bibr" rid="CR21">21</xref>, <xref ref-type="bibr" rid="CR108">108</xref>–<xref ref-type="bibr" rid="CR110">110</xref>]. In the same way, production of pyruvate is stimulated [<xref ref-type="bibr" rid="CR20">20</xref>, <xref ref-type="bibr" rid="CR110">110</xref>] but with an increased ratio lactate-to-pyruvate [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR20">20</xref>]. A recent study has observed a significant increase in LDH-A expression and pyruvate levels in ASD [<xref ref-type="bibr" rid="CR18">18</xref>]. A recent study have shown a decrease level of pH associated with the overproduction of lactate in ASD [<xref ref-type="bibr" rid="CR111">111</xref>]. These findings may suggest an elevation of glycolysis through the phenomenon of aerobic glycolysis in ASD since the dysregulation of this balance has been proposed as a candidate cause of ASD [<xref ref-type="bibr" rid="CR112">112</xref>].</p>
<p id="Par45">The canonical WNT/β-catenin pathway is upregulated in ASD, and is one of the major pathways involved in developmental cognitive disorders. In the present review, we examine accumulating evidence of the reprogramming of cellular energy metabolism induced by over-expressed canonical WNT/β-catenin pathway for a shift in energy production from mitochondrial oxidative phosphorylation to aerobic glycolysis as the alternative of ATP despite the availability of oxygen; a phenomenon called Warburg effect. Over-activation of the WNT/β-catenin pathway induces the transduction of WNT/β-catenin target genes, c-Myc and cyclin D1, and activates PI3K/Akt pathway, leading to HIF-1α stabilization. Both transcription of WNT-responsive genes and HIF-1α stabilization induce the transactivation of genes encoding aerobic glycolysis enzymes c-Myc, PDK, LDH-A, and MCT-1, which might explain the decreased glucose entry into the TCA cycle in mitochondria, and the conversion of a large part of glucose into lactate in cytosol, observed in the ASD. Dysregulation of cellular energy metabolism induced by over-expressed canonical WNT/β-catenin pathway might promote dysregulation and progression of the core neurodevelopmental pathways associated with the clinical presentation of ASD. Warburg effect regulation might be an innovative mechanism for therapeutic development in ASD, through the canonical WNT/β-catenin pathway as potential therapeutic target.</p>
</sec>
</sec>
</sec>
</body>
<back>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item>
<term>Acetyl-coA</term>
<def>
<p id="Par2">Acetyl-coenzyme A</p>
</def>
</def-item>
<def-item>
<term>APC</term>
<def>
<p id="Par3">Adenomatous polyposis coli</p>
</def>
</def-item>
<def-item>
<term>ASD</term>
<def>
<p id="Par4">Autism spectrum disorders</p>
</def>
</def-item>
<def-item>
<term>CNS</term>
<def>
<p id="Par5">Central nervous system</p>
</def>
</def-item>
<def-item>
<term>DSH</term>
<def>
<p id="Par6">Disheveled</p>
</def>
</def-item>
<def-item>
<term>FZD</term>
<def>
<p id="Par7">Frizzled</p>
</def>
</def-item>
<def-item>
<term>GLUT</term>
<def>
<p id="Par8">Glucose transporter</p>
</def>
</def-item>
<def-item>
<term>GSK-3β</term>
<def>
<p id="Par9">Glycogen synthase kinase-3β</p>
</def>
</def-item>
<def-item>
<term>HIF-1α</term>
<def>
<p id="Par10">Hypoxia induce factor 1 alpha</p>
</def>
</def-item>
<def-item>
<term>LDH</term>
<def>
<p id="Par11">Lactate dehydrogenase</p>
</def>
</def-item>
<def-item>
<term>LRP 5/6</term>
<def>
<p id="Par12">Low-density lipoprotein receptor-related protein 5/6</p>
</def>
</def-item>
<def-item>
<term>MCT-1</term>
<def>
<p id="Par13">Monocarboxylate lactate transporter-1</p>
</def>
</def-item>
<def-item>
<term>PDH</term>
<def>
<p id="Par14">Pyruvate dehydrogenase complex</p>
</def>
</def-item>
<def-item>
<term>PDK</term>
<def>
<p id="Par15">Pyruvate dehydrogenase kinase</p>
</def>
</def-item>
<def-item>
<term>PI3K-Akt</term>
<def>
<p id="Par16">Phosphatidylinositol 3-kinase-protein kinase B</p>
</def>
</def-item>
<def-item>
<term>PK</term>
<def>
<p id="Par17">Pyruvate kinase</p>
</def>
</def-item>
<def-item>
<term>ROS</term>
<def>
<p id="Par18">Reactive oxygen species</p>
</def>
</def-item>
<def-item>
<term>TCA</term>
<def>
<p id="Par19">Tricarboxylic acid</p>
</def>
</def-item>
<def-item>
<term>TCF/LEF</term>
<def>
<p id="Par20">T-cell factor/lymphoid enhancer factor</p>
</def>
</def-item>
<def-item>
<term>VPA</term>
<def>
<p id="Par21">Valproic acid</p>
</def>
</def-item>
</def-list>
</glossary>
<ack>
<title>Acknowledgements</title>
<p>Not applicable.</p>
<sec id="FPar1">
<title>Funding</title>
<p id="Par46">No funding.</p>
</sec>
<sec id="FPar2">
<title>Availability of data and materials</title>
<p id="Par47">Data sharing not applicable to this article as no datasets were generated or analyzed during the current study.</p>
</sec>
</ack>
<notes notes-type="author-contribution">
<title>Authors’ contributions</title>
<p>Both authors listed, have made substantial, direct and intellectual contribution to the work. Both authors read and approved the final manuscript.</p>
</notes>
<notes notes-type="COI-statement">
<sec id="FPar3">
<title>Ethics approval and consent to participate</title>
<p id="Par48">Not applicable.</p>
</sec>
<sec id="FPar4">
<title>Consent for publication</title>
<p id="Par49">Not applicable.</p>
</sec>
<sec id="FPar5">
<title>Competing interests</title>
<p id="Par50">The authors declare that they have no competing interests.</p>
</sec>
<sec id="FPar6">
<title>Publisher’s Note</title>
<p id="Par51">Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
</sec>
</notes>
<ref-list id="Bib1">
<title>References</title>
<ref id="CR1">
<label>1.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Posar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Resca</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Visconti</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Autism according to diagnostic and statistical manual of mental disorders 5(th) edition: the need for further improvements</article-title>
<source/>J Pediatr Neurosci
          <year>2015</year>
<volume>10</volume>
<fpage>146</fpage>
<lpage>148</lpage>
<pub-id pub-id-type="pmid">26167220</pub-id>
</element-citation>
</ref>
<ref id="CR2">
<label>2.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Esposito</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Venuti</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>Analysis of toddlers’ gait after six months of independent walking to identify autism: a preliminary study</article-title>
<source/>Percept Mot Skills
          <year>2008</year>
<volume>106</volume>
<fpage>259</fpage>
<lpage>269</lpage>
<pub-id pub-id-type="pmid">18459375</pub-id>
</element-citation>
</ref>
<ref id="CR3">
<label>3.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Esposito</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Venuti</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Maestro</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Muratori</surname>
<given-names>F</given-names>
</name>
</person-group>
<article-title>An exploration of symmetry in early autism spectrum disorders: analysis of lying</article-title>
<source/>Brain and Development
          <year>2009</year>
<volume>31</volume>
<fpage>131</fpage>
<lpage>138</lpage>
<pub-id pub-id-type="pmid">18534798</pub-id>
</element-citation>
</ref>
<ref id="CR4">
<label>4.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ospina</surname>
<given-names>MB</given-names>
</name>
<name>
<surname>Krebs Seida</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Karkhaneh</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hartling</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Tjosvold</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Behavioural and developmental interventions for autism spectrum disorder: a clinical systematic review</article-title>
<source/>PLoS One
          <year>2008</year>
<volume>3</volume>
<fpage>e3755</fpage>
<pub-id pub-id-type="pmid">19015734</pub-id>
</element-citation>
</ref>
<ref id="CR5">
<label>5.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Altemeier</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Altemeier</surname>
<given-names>LE</given-names>
</name>
</person-group>
<article-title>How can early, intensive training help a genetic disorder?</article-title>
<source/>Pediatr Ann
          <year>2009</year>
<volume>38</volume>
<fpage>167</fpage>
<lpage>170</lpage>
<pub-id pub-id-type="pmid">19353907</pub-id>
</element-citation>
</ref>
<ref id="CR6">
<label>6.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Persico</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Napolioni</surname>
<given-names>V</given-names>
</name>
</person-group>
<article-title>Autism genetics</article-title>
<source/>Behav Brain Res
          <year>2013</year>
<volume>251</volume>
<fpage>95</fpage>
<lpage>112</lpage>
<pub-id pub-id-type="pmid">23769996</pub-id>
</element-citation>
</ref>
<ref id="CR7">
<label>7.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kwan</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Unda</surname>
<given-names>BK</given-names>
</name>
<name>
<surname>Singh</surname>
<given-names>KK</given-names>
</name>
</person-group>
<article-title>Wnt signaling networks in autism spectrum disorder and intellectual disability</article-title>
<source/>J Neurodev Disord
          <year>2016</year>
<volume>8</volume>
<fpage>45</fpage>
<pub-id pub-id-type="pmid">27980692</pub-id>
</element-citation>
</ref>
<ref id="CR8">
<label>8.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Krumm</surname>
<given-names>N</given-names>
</name>
<name>
<surname>O’Roak</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Shendure</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Eichler</surname>
<given-names>EEA</given-names>
</name>
</person-group>
<article-title>De novo convergence of autism genetics and molecular neuroscience</article-title>
<source/>Trends Neurosci
          <year>2014</year>
<volume>37</volume>
<fpage>95</fpage>
<lpage>105</lpage>
<pub-id pub-id-type="pmid">24387789</pub-id>
</element-citation>
</ref>
<ref id="CR9">
<label>9.</label>
<mixed-citation publication-type="other">Caracci MO, Ávila ME, De Ferrari GV. Synaptic Wnt/GSK3β signaling hub in autism. Neural Plast 2016;2016:9603751.</mixed-citation>
</ref>
<ref id="CR10">
<label>10.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mulligan</surname>
<given-names>KA</given-names>
</name>
<name>
<surname>Cheyette</surname>
<given-names>BNR</given-names>
</name>
</person-group>
<article-title>Neurodevelopmental perspectives on Wnt signaling in psychiatry. Mol</article-title>
<source/>Neuropsychiatry
          <year>2017</year>
<volume>2</volume>
<fpage>219</fpage>
<lpage>246</lpage>
</element-citation>
</ref>
<ref id="CR11">
<label>11.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pate</surname>
<given-names>KT</given-names>
</name>
<name>
<surname>Stringari</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Sprowl-Tanio</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>K</given-names>
</name>
<name>
<surname>TeSlaa</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Hoverter</surname>
<given-names>NP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Wnt signaling directs a metabolic program of glycolysis and angiogenesis in colon cancer</article-title>
<source/>EMBO J
          <year>2014</year>
<volume>33</volume>
<fpage>1454</fpage>
<lpage>1473</lpage>
<pub-id pub-id-type="pmid">24825347</pub-id>
</element-citation>
</ref>
<ref id="CR12">
<label>12.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Warburg</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>On the origin of cancer cells</article-title>
<source/>Science
          <year>1956</year>
<volume>123</volume>
<fpage>309</fpage>
<lpage>314</lpage>
<pub-id pub-id-type="pmid">13298683</pub-id>
</element-citation>
</ref>
<ref id="CR13">
<label>13.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frye</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Rossignol</surname>
<given-names>DA</given-names>
</name>
</person-group>
<article-title>Mitochondrial dysfunction can connect the diverse medical symptoms associated with autism spectrum disorders</article-title>
<source/>Pediatr Res
          <year>2011</year>
<volume>69</volume>
<fpage>41R</fpage>
<lpage>47R</lpage>
<pub-id pub-id-type="pmid">21289536</pub-id>
</element-citation>
</ref>
<ref id="CR14">
<label>14.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rossignol</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Frye</surname>
<given-names>RE</given-names>
</name>
</person-group>
<article-title>Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis</article-title>
<source/>Mol Psychiatry
          <year>2012</year>
<volume>17</volume>
<fpage>290</fpage>
<lpage>314</lpage>
<pub-id pub-id-type="pmid">21263444</pub-id>
</element-citation>
</ref>
<ref id="CR15">
<label>15.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rossignol</surname>
<given-names>DA</given-names>
</name>
<name>
<surname>Frye</surname>
<given-names>REA</given-names>
</name>
</person-group>
<article-title>Review of research trends in physiological abnormalities in autism spectrum disorders: immune dysregulation, inflammation, oxidative stress, mitochondrial dysfunction and environmental toxicant exposures</article-title>
<source/>Mol Psychiatry
          <year>2012</year>
<volume>17</volume>
<fpage>389</fpage>
<lpage>401</lpage>
<pub-id pub-id-type="pmid">22143005</pub-id>
</element-citation>
</ref>
<ref id="CR16">
<label>16.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Goh</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Z</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>DiMauro</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Peterson</surname>
<given-names>BS</given-names>
</name>
</person-group>
<article-title>Mitochondrial dysfunction as a neurobiological subtype of autism spectrum disorder: evidence from brain imaging</article-title>
<source/>JAMA Psychiatry
          <year>2014</year>
<volume>71</volume>
<fpage>665</fpage>
<lpage>671</lpage>
<pub-id pub-id-type="pmid">24718932</pub-id>
</element-citation>
</ref>
<ref id="CR17">
<label>17.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hollis</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Kanellopoulos</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Bagni</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Mitochondrial dysfunction in autism Spectrum disorder: clinical features and perspectives</article-title>
<source/>Curr Opin Neurobiol
          <year>2017</year>
<volume>45</volume>
<fpage>178</fpage>
<lpage>187</lpage>
<pub-id pub-id-type="pmid">28628841</pub-id>
</element-citation>
</ref>
<ref id="CR18">
<label>18.</label>
<mixed-citation publication-type="other">Khemakhem AM, Frye RE, El-Ansary A, Al-Ayadhi L, Bacha AB. Novel biomarkers of metabolic dysfunction is autism spectrum disorder: potential for biological diagnostic markers. Metab Brain Dis. 2017.</mixed-citation>
</ref>
<ref id="CR19">
<label>19.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Correia</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Coutinho</surname>
<given-names>AM</given-names>
</name>
<name>
<surname>Diogo</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Grazina</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Marques</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Miguel</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Brief report: high frequency of biochemical markers for mitochondrial dysfunction in autism: no association with the mitochondrial aspartate/glutamate carrier SLC25A12 gene</article-title>
<source/>J Autism Dev Disord
          <year>2006</year>
<volume>36</volume>
<fpage>1137</fpage>
<lpage>1140</lpage>
<pub-id pub-id-type="pmid">17151801</pub-id>
</element-citation>
</ref>
<ref id="CR20">
<label>20.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>László</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Horváth</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Eck</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Fekete</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Serum serotonin, lactate and pyruvate levels in infantile autistic children</article-title>
<source/>Clin. Chim. Acta Int. J Clin Chem
          <year>1994</year>
<volume>229</volume>
<fpage>205</fpage>
<lpage>207</lpage>
</element-citation>
</ref>
<ref id="CR21">
<label>21.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Weissman</surname>
<given-names>JR</given-names>
</name>
<name>
<surname>Kelley</surname>
<given-names>RI</given-names>
</name>
<name>
<surname>Bauman</surname>
<given-names>ML</given-names>
</name>
<name>
<surname>Cohen</surname>
<given-names>BH</given-names>
</name>
<name>
<surname>Murray</surname>
<given-names>KF</given-names>
</name>
<name>
<surname>Mitchell</surname>
<given-names>RL</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mitochondrial disease in autism spectrum disorder patients: a cohort analysis</article-title>
<source/>PLoS One
          <year>2008</year>
<volume>3</volume>
<fpage>e3815</fpage>
<pub-id pub-id-type="pmid">19043581</pub-id>
</element-citation>
</ref>
<ref id="CR22">
<label>22.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>van Amerongen</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Nusse</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Towards an integrated view of Wnt signaling in development</article-title>
<source/>Dev. Camb. Engl
          <year>2009</year>
<volume>136</volume>
<fpage>3205</fpage>
<lpage>3214</lpage>
</element-citation>
</ref>
<ref id="CR23">
<label>23.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Al-Harthi</surname>
<given-names>L</given-names>
</name>
</person-group>
<article-title>Wnt/β-catenin and its diverse physiological cell signaling pathways in neurodegenerative and neuropsychiatric disorders</article-title>
<source/>J NeuroImmune Pharmacol
          <year>2012</year>
<volume>7</volume>
<fpage>725</fpage>
<lpage>730</lpage>
<pub-id pub-id-type="pmid">23114888</pub-id>
</element-citation>
</ref>
<ref id="CR24">
<label>24.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahmad-Annuar</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ciani</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Simeonidis</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Herreros</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Fredj</surname>
<given-names>NB</given-names>
</name>
<name>
<surname>Rosso</surname>
<given-names>SB</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Signaling across the synapse: a role for Wnt and Dishevelled in presynaptic assembly and neurotransmitter release</article-title>
<source/>J Cell Biol
          <year>2006</year>
<volume>174</volume>
<fpage>127</fpage>
<lpage>139</lpage>
<pub-id pub-id-type="pmid">16818724</pub-id>
</element-citation>
</ref>
<ref id="CR25">
<label>25.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Inestrosa</surname>
<given-names>NC</given-names>
</name>
<name>
<surname>Arenas</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Emerging roles of Wnts in the adult nervous system</article-title>
<source/>Nat Rev Neurosci
          <year>2010</year>
<volume>11</volume>
<fpage>77</fpage>
<lpage>86</lpage>
<pub-id pub-id-type="pmid">20010950</pub-id>
</element-citation>
</ref>
<ref id="CR26">
<label>26.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Itasaki</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Jones</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Mercurio</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Rowe</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Domingos</surname>
<given-names>PM</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>JC</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Wise, a context-dependent activator and inhibitor of Wnt signalling</article-title>
<source/>Dev Camb Engl
          <year>2003</year>
<volume>130</volume>
<fpage>4295</fpage>
<lpage>4305</lpage>
</element-citation>
</ref>
<ref id="CR27">
<label>27.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caricasole</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Ferraro</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Iacovelli</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Barletta</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Caruso</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Melchiorri</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Functional characterization of WNT7A signaling in PC12 cells: interaction with a FZD5 x LRP6 receptor complex and modulation by Dickkopf proteins</article-title>
<source/>J Biol Chem
          <year>2003</year>
<volume>278</volume>
<fpage>37024</fpage>
<lpage>37031</lpage>
<pub-id pub-id-type="pmid">12857724</pub-id>
</element-citation>
</ref>
<ref id="CR28">
<label>28.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sharma</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>S-Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Nieland</surname>
<given-names>TJF</given-names>
</name>
<name>
<surname>Long</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>High-throughput genetic screen for synaptogenic factors: identification of LRP6 as critical for excitatory synapse development</article-title>
<source/>Cell Rep
          <year>2013</year>
<volume>5</volume>
<fpage>1330</fpage>
<lpage>1341</lpage>
<pub-id pub-id-type="pmid">24316074</pub-id>
</element-citation>
</ref>
<ref id="CR29">
<label>29.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lecarpentier</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Claes</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Duthoit</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Hébert</surname>
<given-names>J-L</given-names>
</name>
</person-group>
<article-title>Circadian rhythms, Wnt/beta-catenin pathway and PPAR alpha/gamma profiles in diseases with primary or secondary cardiac dysfunction</article-title>
<source/>Front Physiol
          <year>2014</year>
<volume>5</volume>
<fpage>429</fpage>
<pub-id pub-id-type="pmid">25414671</pub-id>
</element-citation>
</ref>
<ref id="CR30">
<label>30.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vallée</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lecarpentier</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Guillevin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Vallée</surname>
<given-names>J-N</given-names>
</name>
</person-group>
<article-title>Thermodynamics in gliomas: interactions between the canonical WNT/Beta-catenin pathway and PPAR gamma</article-title>
<source/>Front Physiol
          <year>2017</year>
<volume>8</volume>
<fpage>352</fpage>
<pub-id pub-id-type="pmid">28620312</pub-id>
</element-citation>
</ref>
<ref id="CR31">
<label>31.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vallée</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Guillevin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Vallée</surname>
<given-names>J-N</given-names>
</name>
</person-group>
<article-title>Vasculogenesis and angiogenesis initiation under normoxic conditions through Wnt/β-catenin pathway in gliomas</article-title>
<source/>Rev Neurosci
          <year>2018</year>
<volume>29</volume>
<issue>1</issue>
<fpage>71</fpage>
<lpage>91</lpage>
<pub-id pub-id-type="pmid">28822229</pub-id>
</element-citation>
</ref>
<ref id="CR32">
<label>32.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lecarpentier</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Claes</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Vallée</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hébert</surname>
<given-names>J-L</given-names>
</name>
</person-group>
<article-title>Interactions between PPAR gamma and the canonical Wnt/Beta-catenin pathway in type 2 diabetes and colon cancer</article-title>
<source/>PPAR Res
          <year>2017</year>
<volume>2017</volume>
<fpage>1</fpage>
<lpage>9</lpage>
</element-citation>
</ref>
<ref id="CR33">
<label>33.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vallée</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lecarpentier</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Alzheimer disease: crosstalk between the canonical Wnt/Beta-catenin pathway and PPARs alpha and gamma</article-title>
<source/>Front Neurosci
          <year>2016</year>
<volume>10</volume>
<fpage>459</fpage>
<pub-id pub-id-type="pmid">27807401</pub-id>
</element-citation>
</ref>
<ref id="CR34">
<label>34.</label>
<mixed-citation publication-type="other">Vallée A, Lecarpentier Y, Guillevin R, Vallée J-N. Effects of Cannabidiol interactions with Wnt/β-catenin pathway and PPARγ on oxidative stress and neuroinflammation in Alzheimer’s disease. Acta Biochim Biophys Sin. 2017:1–14.</mixed-citation>
</ref>
<ref id="CR35">
<label>35.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vallée</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lecarpentier</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Guillevin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Vallée</surname>
<given-names>J-N</given-names>
</name>
</person-group>
<article-title>Aerobic glycolysis hypothesis through WNT/Beta-catenin pathway in exudative age-related macular degeneration</article-title>
<source/>J Mol Neurosci MN
          <year>2017</year>
<volume>62</volume>
<fpage>368</fpage>
<lpage>379</lpage>
<pub-id pub-id-type="pmid">28689265</pub-id>
</element-citation>
</ref>
<ref id="CR36">
<label>36.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vallée</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lecarpentier</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Guillevin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Vallée</surname>
<given-names>J-N</given-names>
</name>
</person-group>
<article-title>PPARγ agonists: potential treatments for exudative age-related macular degeneration</article-title>
<source/>Life Sci.
          <year>2017</year>
<volume>188</volume>
<fpage>123</fpage>
<lpage>30</lpage>
<pub-id pub-id-type="pmid">28887057</pub-id>
</element-citation>
</ref>
<ref id="CR37">
<label>37.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lecarpentier</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Vallée</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>Opposite interplay between PPAR gamma and canonical Wnt/Beta-catenin pathway in amyotrophic lateral sclerosis</article-title>
<source/>Front Neurol
          <year>2016</year>
<volume>7</volume>
<fpage>100</fpage>
<pub-id pub-id-type="pmid">27445967</pub-id>
</element-citation>
</ref>
<ref id="CR38">
<label>38.</label>
<mixed-citation publication-type="other">Vallée A, Vallée J-N, Guillevin R, Lecarpentier Y. Interactions between the canonical WNT/Beta-catenin pathway and PPAR gamma on Neuroinflammation, demyelination, and Remyelination in multiple sclerosis. Cell Mol Neurobiol. 2017. 10.1007/s10571-017-0550-9.</mixed-citation>
</ref>
<ref id="CR39">
<label>39.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marchetti</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Pluchino</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Wnt your brain be inflamed? Yes, it Wnt</article-title>
<source/>Trends Mol Med
          <year>2013</year>
<volume>19</volume>
<fpage>144</fpage>
<lpage>156</lpage>
<pub-id pub-id-type="pmid">23312954</pub-id>
</element-citation>
</ref>
<ref id="CR40">
<label>40.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Logan</surname>
<given-names>CY</given-names>
</name>
<name>
<surname>Nusse</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>The Wnt signaling pathway in development and disease</article-title>
<source/>Annu Rev Cell Dev Biol
          <year>2004</year>
<volume>20</volume>
<fpage>781</fpage>
<lpage>810</lpage>
<pub-id pub-id-type="pmid">15473860</pub-id>
</element-citation>
</ref>
<ref id="CR41">
<label>41.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Angers</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Moon</surname>
<given-names>RT</given-names>
</name>
</person-group>
<article-title>Proximal events in Wnt signal transduction</article-title>
<source/>Nat Rev Mol Cell Biol
          <year>2009</year>
<volume>10</volume>
<issue>7</issue>
<fpage>468</fpage>
<lpage>77</lpage>
<pub-id pub-id-type="pmid">19536106</pub-id>
</element-citation>
</ref>
<ref id="CR42">
<label>42.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Clevers</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Nusse</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>Wnt/β-catenin signaling and disease</article-title>
<source/>Cell
          <year>2012</year>
<volume>149</volume>
<fpage>1192</fpage>
<lpage>1205</lpage>
<pub-id pub-id-type="pmid">22682243</pub-id>
</element-citation>
</ref>
<ref id="CR43">
<label>43.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Aberle</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Bauer</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Stappert</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Kispert</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Kemler</surname>
<given-names>R</given-names>
</name>
</person-group>
<article-title>β-catenin is a target for the ubiquitin–proteasome pathway</article-title>
<source/>EMBO J
          <year>1997</year>
<volume>16</volume>
<fpage>3797</fpage>
<lpage>3804</lpage>
<pub-id pub-id-type="pmid">9233789</pub-id>
</element-citation>
</ref>
<ref id="CR44">
<label>44.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brazil</surname>
<given-names>DP</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Z-Z</given-names>
</name>
<name>
<surname>Hemmings</surname>
<given-names>BA</given-names>
</name>
</person-group>
<article-title>Advances in protein kinase B signalling: AKTion on multiple fronts</article-title>
<source/>Trends Biochem Sci
          <year>2004</year>
<volume>29</volume>
<fpage>233</fpage>
<lpage>242</lpage>
<pub-id pub-id-type="pmid">15130559</pub-id>
</element-citation>
</ref>
<ref id="CR45">
<label>45.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ciuffreda</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Di Sanza</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Incani</surname>
<given-names>UC</given-names>
</name>
<name>
<surname>Milella</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>The mTOR pathway: a new target in cancer therapy</article-title>
<source/>Curr Cancer Drug Targets
          <year>2010</year>
<volume>10</volume>
<fpage>484</fpage>
<lpage>495</lpage>
<pub-id pub-id-type="pmid">20384580</pub-id>
</element-citation>
</ref>
<ref id="CR46">
<label>46.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Heras-Sandoval</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Pérez-Rojas</surname>
<given-names>JM</given-names>
</name>
<name>
<surname>Hernández-Damián</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pedraza-Chaverri</surname>
<given-names>J</given-names>
</name>
</person-group>
<article-title>The role of PI3K/AKT/mTOR pathway in the modulation of autophagy and the clearance of protein aggregates in neurodegeneration</article-title>
<source/>Cell Signal
          <year>2014</year>
<volume>26</volume>
<fpage>2694</fpage>
<lpage>2701</lpage>
<pub-id pub-id-type="pmid">25173700</pub-id>
</element-citation>
</ref>
<ref id="CR47">
<label>47.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>JSL</given-names>
</name>
<name>
<surname>Cui</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>Proliferation, survival and metabolism: the role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination</article-title>
<source/>Dev. Camb. Engl
          <year>2016</year>
<volume>143</volume>
<fpage>3050</fpage>
<lpage>3060</lpage>
</element-citation>
</ref>
<ref id="CR48">
<label>48.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Nguyen-McCarty</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Hexner</surname>
<given-names>EO</given-names>
</name>
<name>
<surname>Danet-Desnoyers</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>PS</given-names>
</name>
</person-group>
<article-title>Maintenance of hematopoietic stem cells through regulation of Wnt and mTOR pathways</article-title>
<source/>Nat Med
          <year>2012</year>
<volume>18</volume>
<fpage>1778</fpage>
<lpage>1785</lpage>
<pub-id pub-id-type="pmid">23142822</pub-id>
</element-citation>
</ref>
<ref id="CR49">
<label>49.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Alberts</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
</person-group>
<article-title>Dysregulation of the IGF-I/PI3K/AKT/mTOR signaling pathway in autism spectrum disorders. Int. J. Dev. Neurosci</article-title>
<source/>Off. J. Int. Soc Dev Neurosci
          <year>2014</year>
<volume>35</volume>
<fpage>35</fpage>
<lpage>41</lpage>
</element-citation>
</ref>
<ref id="CR50">
<label>50.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Buckley</surname>
<given-names>ST</given-names>
</name>
<name>
<surname>Patel</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Krishnaveni</surname>
<given-names>MS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Troglitazone attenuates TGF-β1-induced EMT in alveolar epithelial cells via a PPARγ-independent mechanism</article-title>
<source/>PLoS One
          <year>2012</year>
<volume>7</volume>
<fpage>e38827</fpage>
<pub-id pub-id-type="pmid">22745681</pub-id>
</element-citation>
</ref>
<ref id="CR51">
<label>51.</label>
<mixed-citation publication-type="other">Ambacher KK, Pitzul KB, Karajgikar M, Hamilton A, Ferguson SS, Cregan SP. The JNK- and AKT/GSK3β- signaling pathways converge to regulate puma induction and neuronal apoptosis induced by trophic factor deprivation. Hetman M, editor. PLoS One 2012;7:e46885.</mixed-citation>
</ref>
<ref id="CR52">
<label>52.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hur</surname>
<given-names>E-M</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>F-Q</given-names>
</name>
</person-group>
<article-title>GSK3 signalling in neural development</article-title>
<source/>Nat Rev Neurosci
          <year>2010</year>
<volume>11</volume>
<fpage>539</fpage>
<lpage>551</lpage>
<pub-id pub-id-type="pmid">20648061</pub-id>
</element-citation>
</ref>
<ref id="CR53">
<label>53.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wu</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Pan</surname>
<given-names>W</given-names>
</name>
</person-group>
<article-title>GSK3: a multifaceted kinase in Wnt signaling</article-title>
<source/>Trends Biochem Sci
          <year>2010</year>
<volume>35</volume>
<fpage>161</fpage>
<lpage>168</lpage>
<pub-id pub-id-type="pmid">19884009</pub-id>
</element-citation>
</ref>
<ref id="CR54">
<label>54.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ross</surname>
<given-names>SE</given-names>
</name>
<name>
<surname>Erickson</surname>
<given-names>RL</given-names>
</name>
<name>
<surname>Hemati</surname>
<given-names>N</given-names>
</name>
<name>
<surname>MacDougald</surname>
<given-names>OA</given-names>
</name>
</person-group>
<article-title>Glycogen synthase kinase 3 is an insulin-regulated C/EBPalpha kinase</article-title>
<source/>Mol Cell Biol
          <year>1999</year>
<volume>19</volume>
<fpage>8433</fpage>
<lpage>8441</lpage>
<pub-id pub-id-type="pmid">10567568</pub-id>
</element-citation>
</ref>
<ref id="CR55">
<label>55.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tang</surname>
<given-names>Q-Q</given-names>
</name>
<name>
<surname>Grønborg</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J-W</given-names>
</name>
<name>
<surname>Otto</surname>
<given-names>TC</given-names>
</name>
<name>
<surname>Pandey</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sequential phosphorylation of CCAAT enhancer-binding protein beta by MAPK and glycogen synthase kinase 3beta is required for adipogenesis</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2005</year>
<volume>102</volume>
<fpage>9766</fpage>
<lpage>9771</lpage>
<pub-id pub-id-type="pmid">15985551</pub-id>
</element-citation>
</ref>
<ref id="CR56">
<label>56.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Park</surname>
<given-names>KS</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>RD</given-names>
</name>
<name>
<surname>Kang</surname>
<given-names>S-K</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>SY</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>KH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neuronal differentiation of embryonic midbrain cells by upregulation of peroxisome proliferator-activated receptor-gamma via the JNK-dependent pathway</article-title>
<source/>Exp Cell Res
          <year>2004</year>
<volume>297</volume>
<fpage>424</fpage>
<lpage>433</lpage>
<pub-id pub-id-type="pmid">15212945</pub-id>
</element-citation>
</ref>
<ref id="CR57">
<label>57.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yue</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Lan</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Interruption of β-catenin suppresses the EGFR pathway by blocking multiple oncogenic targets in human glioma cells</article-title>
<source/>Brain Res
          <year>2010</year>
<volume>1366</volume>
<fpage>27</fpage>
<lpage>37</lpage>
<pub-id pub-id-type="pmid">20969832</pub-id>
</element-citation>
</ref>
<ref id="CR58">
<label>58.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>De Ferrari</surname>
<given-names>GV</given-names>
</name>
<name>
<surname>Moon</surname>
<given-names>RT</given-names>
</name>
</person-group>
<article-title>The ups and downs of Wnt signaling in prevalent neurological disorders</article-title>
<source/>Oncogene
          <year>2006</year>
<volume>25</volume>
<fpage>7545</fpage>
<lpage>7553</lpage>
<pub-id pub-id-type="pmid">17143299</pub-id>
</element-citation>
</ref>
<ref id="CR59">
<label>59.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Okerlund</surname>
<given-names>ND</given-names>
</name>
<name>
<surname>Cheyette</surname>
<given-names>BNR</given-names>
</name>
</person-group>
<article-title>Synaptic Wnt signaling-a contributor to major psychiatric disorders?</article-title>
<source/>J Neurodev Disord
          <year>2011</year>
<volume>3</volume>
<fpage>162</fpage>
<lpage>174</lpage>
<pub-id pub-id-type="pmid">21533542</pub-id>
</element-citation>
</ref>
<ref id="CR60">
<label>60.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kalkman</surname>
<given-names>HOA</given-names>
</name>
</person-group>
<article-title>Review of the evidence for the canonical Wnt pathway in autism spectrum disorders. Mol</article-title>
<source/>Autism
          <year>2012</year>
<volume>3</volume>
<fpage>10</fpage>
</element-citation>
</ref>
<ref id="CR61">
<label>61.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wassink</surname>
<given-names>TH</given-names>
</name>
<name>
<surname>Piven</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Vieland</surname>
<given-names>VJ</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Swiderski</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Pietila</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Evidence supporting WNT2 as an autism susceptibility gene</article-title>
<source/>Am J Med Genet
          <year>2001</year>
<volume>105</volume>
<fpage>406</fpage>
<lpage>413</lpage>
<pub-id pub-id-type="pmid">11449391</pub-id>
</element-citation>
</ref>
<ref id="CR62">
<label>62.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boon</surname>
<given-names>EMJ</given-names>
</name>
<name>
<surname>van der Neut</surname>
<given-names>R</given-names>
</name>
<name>
<surname>van de Wetering</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Clevers</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Pals</surname>
<given-names>ST</given-names>
</name>
</person-group>
<article-title>Wnt signaling regulates expression of the receptor tyrosine kinase met in colorectal cancer</article-title>
<source/>Cancer Res
          <year>2002</year>
<volume>62</volume>
<fpage>5126</fpage>
<lpage>5128</lpage>
<pub-id pub-id-type="pmid">12234972</pub-id>
</element-citation>
</ref>
<ref id="CR63">
<label>63.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tuynman</surname>
<given-names>JB</given-names>
</name>
<name>
<surname>Vermeulen</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Boon</surname>
<given-names>EM</given-names>
</name>
<name>
<surname>Kemper</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Zwinderman</surname>
<given-names>AH</given-names>
</name>
<name>
<surname>Peppelenbosch</surname>
<given-names>MP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Cyclooxygenase-2 inhibition inhibits c-met kinase activity and Wnt activity in colon cancer</article-title>
<source/>Cancer Res
          <year>2008</year>
<volume>68</volume>
<fpage>1213</fpage>
<lpage>1220</lpage>
<pub-id pub-id-type="pmid">18281498</pub-id>
</element-citation>
</ref>
<ref id="CR64">
<label>64.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thompson</surname>
<given-names>BA</given-names>
</name>
<name>
<surname>Tremblay</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>G</given-names>
</name>
</person-group>
<article-title>Bochar DA. CHD8 is an ATP-dependent chromatin remodeling factor that regulates beta-catenin target genes</article-title>
<source/>Mol Cell Biol
          <year>2008</year>
<volume>28</volume>
<fpage>3894</fpage>
<lpage>3904</lpage>
<pub-id pub-id-type="pmid">18378692</pub-id>
</element-citation>
</ref>
<ref id="CR65">
<label>65.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Roak</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Deriziotis</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Vives</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Schwartz</surname>
<given-names>JJ</given-names>
</name>
<name>
<surname>Girirajan</surname>
<given-names>S</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Exome sequencing in sporadic autism spectrum disorders identifies severe de novo mutations</article-title>
<source/>Nat Genet
          <year>2011</year>
<volume>43</volume>
<fpage>585</fpage>
<lpage>589</lpage>
<pub-id pub-id-type="pmid">21572417</pub-id>
</element-citation>
</ref>
<ref id="CR66">
<label>66.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hong</surname>
<given-names>JY</given-names>
</name>
<name>
<surname>Park</surname>
<given-names>J-I</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Muñoz</surname>
<given-names>WA</given-names>
</name>
<name>
<surname>Miller</surname>
<given-names>RK</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Down’s-syndrome-related kinase Dyrk1A modulates the p120-catenin-kaiso trajectory of the Wnt signaling pathway</article-title>
<source/>J Cell Sci
          <year>2012</year>
<volume>125</volume>
<fpage>561</fpage>
<lpage>569</lpage>
<pub-id pub-id-type="pmid">22389395</pub-id>
</element-citation>
</ref>
<ref id="CR67">
<label>67.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Martin</surname>
<given-names>P-M</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Robin</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Lam</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Rabinowitz</surname>
<given-names>JS</given-names>
</name>
<name>
<surname>Erdman</surname>
<given-names>CA</given-names>
</name>
<etal></etal>
</person-group>
<article-title>A rare WNT1 missense variant overrepresented in ASD leads to increased WNT signal pathway activation</article-title>
<source/>Transl Psychiatry
          <year>2013</year>
<volume>3</volume>
<fpage>e301</fpage>
<pub-id pub-id-type="pmid">24002087</pub-id>
</element-citation>
</ref>
<ref id="CR68">
<label>68.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gilman</surname>
<given-names>SR</given-names>
</name>
<name>
<surname>Iossifov</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Ronemus</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Wigler</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Vitkup</surname>
<given-names>D</given-names>
</name>
</person-group>
<article-title>Rare de novo variants associated with autism implicate a large functional network of genes involved in formation and function of synapses</article-title>
<source/>Neuron
          <year>2011</year>
<volume>70</volume>
<fpage>898</fpage>
<lpage>907</lpage>
<pub-id pub-id-type="pmid">21658583</pub-id>
</element-citation>
</ref>
<ref id="CR69">
<label>69.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Turner</surname>
<given-names>TN</given-names>
</name>
<name>
<surname>Hormozdiari</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Duyzend</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>McClymont</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Hook</surname>
<given-names>PW</given-names>
</name>
<name>
<surname>Iossifov</surname>
<given-names>I</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Genome sequencing of autism-affected families reveals disruption of putative noncoding regulatory DNA</article-title>
<source/>Am J Hum Genet
          <year>2016</year>
<volume>98</volume>
<fpage>58</fpage>
<lpage>74</lpage>
<pub-id pub-id-type="pmid">26749308</pub-id>
</element-citation>
</ref>
<ref id="CR70">
<label>70.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Barber</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Ellis</surname>
<given-names>KH</given-names>
</name>
<name>
<surname>Bowles</surname>
<given-names>LV</given-names>
</name>
<name>
<surname>Delhanty</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Ede</surname>
<given-names>RF</given-names>
</name>
<name>
<surname>Male</surname>
<given-names>BM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Adenomatous polyposis coli and a cytogenetic deletion of chromosome 5 resulting from a maternal intrachromosomal insertion</article-title>
<source/>J Med Genet
          <year>1994</year>
<volume>31</volume>
<fpage>312</fpage>
<lpage>316</lpage>
<pub-id pub-id-type="pmid">8071957</pub-id>
</element-citation>
</ref>
<ref id="CR71">
<label>71.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhou</surname>
<given-names>X-L</given-names>
</name>
<name>
<surname>Giacobini</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Anderlid</surname>
<given-names>B-M</given-names>
</name>
<name>
<surname>Anckarsäter</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Omrani</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Gillberg</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Association of adenomatous polyposis coli (APC) gene polymorphisms with autism spectrum disorder (ASD). Am. J. Med. Genet. Part B Neuropsychiatr</article-title>
<source/>Genet. Off. Publ. Int. Soc Psychiatr Genet
          <year>2007</year>
<volume>144B</volume>
<fpage>351</fpage>
<lpage>354</lpage>
</element-citation>
</ref>
<ref id="CR72">
<label>72.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mohn</surname>
<given-names>JL</given-names>
</name>
<name>
<surname>Alexander</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Pirone</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Palka</surname>
<given-names>CD</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>S-Y</given-names>
</name>
<name>
<surname>Mebane</surname>
<given-names>L</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Adenomatous polyposis coli protein deletion leads to cognitive and autism-like disabilities</article-title>
<source/>Mol Psychiatry
          <year>2014</year>
<volume>19</volume>
<fpage>1133</fpage>
<lpage>1142</lpage>
<pub-id pub-id-type="pmid">24934177</pub-id>
</element-citation>
</ref>
<ref id="CR73">
<label>73.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Roak</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Vives</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Girirajan</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Karakoc</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Krumm</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Coe</surname>
<given-names>BP</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations</article-title>
<source/>Nature
          <year>2012</year>
<volume>485</volume>
<fpage>246</fpage>
<lpage>250</lpage>
<pub-id pub-id-type="pmid">22495309</pub-id>
</element-citation>
</ref>
<ref id="CR74">
<label>74.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Talkowski</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Rosenfeld</surname>
<given-names>JA</given-names>
</name>
<name>
<surname>Blumenthal</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Pillalamarri</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Chiang</surname>
<given-names>C</given-names>
</name>
<name>
<surname>Heilbut</surname>
<given-names>A</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Sequencing chromosomal abnormalities reveals neurodevelopmental loci that confer risk across diagnostic boundaries</article-title>
<source/>Cell
          <year>2012</year>
<volume>149</volume>
<fpage>525</fpage>
<lpage>537</lpage>
<pub-id pub-id-type="pmid">22521361</pub-id>
</element-citation>
</ref>
<ref id="CR75">
<label>75.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lotan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Fenckova</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Bralten</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Alttoa</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Dixson</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Williams</surname>
<given-names>RW</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neuroinformatic analyses of common and distinct genetic components associated with major neuropsychiatric disorders</article-title>
<source/>Front Neurosci
          <year>2014</year>
<volume>8</volume>
<fpage>331</fpage>
<pub-id pub-id-type="pmid">25414627</pub-id>
</element-citation>
</ref>
<ref id="CR76">
<label>76.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Iossifov</surname>
<given-names>I</given-names>
</name>
<name>
<surname>O’Roak</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Sanders</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Ronemus</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Krumm</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Levy</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The contribution of de novo coding mutations to autism spectrum disorder</article-title>
<source/>Nature
          <year>2014</year>
<volume>515</volume>
<fpage>216</fpage>
<lpage>221</lpage>
<pub-id pub-id-type="pmid">25363768</pub-id>
</element-citation>
</ref>
<ref id="CR77">
<label>77.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McBride</surname>
<given-names>KL</given-names>
</name>
<name>
<surname>Varga</surname>
<given-names>EA</given-names>
</name>
<name>
<surname>Pastore</surname>
<given-names>MT</given-names>
</name>
<name>
<surname>Prior</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Manickam</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Atkin</surname>
<given-names>JF</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Confirmation study of PTEN mutations among individuals with autism or developmental delays/mental retardation and macrocephaly</article-title>
<source/>Autism res. Off. J. Int. Soc Autism Res
          <year>2010</year>
<volume>3</volume>
<fpage>137</fpage>
<lpage>141</lpage>
</element-citation>
</ref>
<ref id="CR78">
<label>78.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>O’Roak</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Vives</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Egertson</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Stanaway</surname>
<given-names>IB</given-names>
</name>
<name>
<surname>Phelps</surname>
<given-names>IG</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Multiplex targeted sequencing identifies recurrently mutated genes in autism spectrum disorders</article-title>
<source/>Science
          <year>2012</year>
<volume>338</volume>
<fpage>1619</fpage>
<lpage>1622</lpage>
<pub-id pub-id-type="pmid">23160955</pub-id>
</element-citation>
</ref>
<ref id="CR79">
<label>79.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Spinelli</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Black</surname>
<given-names>FM</given-names>
</name>
<name>
<surname>Berg</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Eickholt</surname>
<given-names>BJ</given-names>
</name>
<name>
<surname>Leslie</surname>
<given-names>NR</given-names>
</name>
</person-group>
<article-title>Functionally distinct groups of inherited PTEN mutations in autism and tumour syndromes</article-title>
<source/>J Med Genet
          <year>2015</year>
<volume>52</volume>
<fpage>128</fpage>
<lpage>134</lpage>
<pub-id pub-id-type="pmid">25527629</pub-id>
</element-citation>
</ref>
<ref id="CR80">
<label>80.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Frazier</surname>
<given-names>TW</given-names>
</name>
<name>
<surname>Embacher</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Tilot</surname>
<given-names>AK</given-names>
</name>
<name>
<surname>Koenig</surname>
<given-names>K</given-names>
</name>
<name>
<surname>Mester</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Eng</surname>
<given-names>C</given-names>
</name>
</person-group>
<article-title>Molecular and phenotypic abnormalities in individuals with germline heterozygous PTEN mutations and autism</article-title>
<source/>Mol Psychiatry
          <year>2015</year>
<volume>20</volume>
<fpage>1132</fpage>
<lpage>1138</lpage>
<pub-id pub-id-type="pmid">25288137</pub-id>
</element-citation>
</ref>
<ref id="CR81">
<label>81.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vanhaesebroeck</surname>
<given-names>B</given-names>
</name>
<name>
<surname>Stephens</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Hawkins</surname>
<given-names>P</given-names>
</name>
</person-group>
<article-title>PI3K signalling: the path to discovery and understanding</article-title>
<source/>Nat Rev Mol Cell Biol
          <year>2012</year>
<volume>13</volume>
<fpage>195</fpage>
<lpage>203</lpage>
<pub-id pub-id-type="pmid">22358332</pub-id>
</element-citation>
</ref>
<ref id="CR82">
<label>82.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mao</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Lebrun</surname>
<given-names>DG</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>VF</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Deregulated signaling pathways in glioblastoma multiforme: molecular mechanisms and therapeutic targets</article-title>
<source/>Cancer Investig
          <year>2012</year>
<volume>30</volume>
<fpage>48</fpage>
<lpage>56</lpage>
<pub-id pub-id-type="pmid">22236189</pub-id>
</element-citation>
</ref>
<ref id="CR83">
<label>83.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kwon</surname>
<given-names>C-H</given-names>
</name>
<name>
<surname>Luikart</surname>
<given-names>BW</given-names>
</name>
<name>
<surname>Powell</surname>
<given-names>CM</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Matheny</surname>
<given-names>SA</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>W</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Pten regulates neuronal arborization and social interaction in mice</article-title>
<source/>Neuron
          <year>2006</year>
<volume>50</volume>
<fpage>377</fpage>
<lpage>388</lpage>
<pub-id pub-id-type="pmid">16675393</pub-id>
</element-citation>
</ref>
<ref id="CR84">
<label>84.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lugo</surname>
<given-names>JN</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>GD</given-names>
</name>
<name>
<surname>Arbuckle</surname>
<given-names>EP</given-names>
</name>
<name>
<surname>White</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Holley</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Floruta</surname>
<given-names>CM</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Deletion of PTEN produces autism-like behavioral deficits and alterations in synaptic proteins</article-title>
<source/>Front Mol Neurosci
          <year>2014</year>
<volume>7</volume>
<fpage>27</fpage>
<pub-id pub-id-type="pmid">24795561</pub-id>
</element-citation>
</ref>
<ref id="CR85">
<label>85.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>W-C</given-names>
</name>
<name>
<surname>Séjourné</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Clipperton-Allen</surname>
<given-names>AE</given-names>
</name>
<name>
<surname>Page</surname>
<given-names>DT</given-names>
</name>
</person-group>
<article-title>Pten mutations Alter brain growth trajectory and allocation of cell types through elevated β-catenin signaling</article-title>
<source/>J Neurosci
          <year>2015</year>
<volume>35</volume>
<fpage>10252</fpage>
<lpage>10267</lpage>
<pub-id pub-id-type="pmid">26180201</pub-id>
</element-citation>
</ref>
<ref id="CR86">
<label>86.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Meunier</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Carraz</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Neunier</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Eymard</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Aimard</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Pharmacodynamic properties of N-dipropylacetic acid</article-title>
<source/>Therapie
          <year>1963</year>
<volume>18</volume>
<fpage>435</fpage>
<lpage>438</lpage>
<pub-id pub-id-type="pmid">13935231</pub-id>
</element-citation>
</ref>
<ref id="CR87">
<label>87.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Peterson</surname>
<given-names>GM</given-names>
</name>
<name>
<surname>Naunton</surname>
<given-names>M</given-names>
</name>
</person-group>
<article-title>Valproate: a simple chemical with so much to offer</article-title>
<source/>J Clin Pharm Ther
          <year>2005</year>
<volume>30</volume>
<fpage>417</fpage>
<lpage>421</lpage>
<pub-id pub-id-type="pmid">16164485</pub-id>
</element-citation>
</ref>
<ref id="CR88">
<label>88.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Phiel</surname>
<given-names>CJ</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>EY</given-names>
</name>
<name>
<surname>Guenther</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Lazar</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>PS</given-names>
</name>
</person-group>
<article-title>Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen</article-title>
<source/>J Biol Chem
          <year>2001</year>
<volume>276</volume>
<fpage>36734</fpage>
<lpage>36741</lpage>
<pub-id pub-id-type="pmid">11473107</pub-id>
</element-citation>
</ref>
<ref id="CR89">
<label>89.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Go</surname>
<given-names>HS</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>KC</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>CS</given-names>
</name>
<name>
<surname>Jeon</surname>
<given-names>SJ</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>KJ</given-names>
</name>
<name>
<surname>Han</surname>
<given-names>S-H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prenatal exposure to valproic acid increases the neural progenitor cell pool and induces macrocephaly in rat brain via a mechanism involving the GSK-3β/β-catenin pathway</article-title>
<source/>Neuropharmacology
          <year>2012</year>
<volume>63</volume>
<fpage>1028</fpage>
<lpage>1041</lpage>
<pub-id pub-id-type="pmid">22841957</pub-id>
</element-citation>
</ref>
<ref id="CR90">
<label>90.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Long</surname>
<given-names>Z-Y</given-names>
</name>
<name>
<surname>Wnt</surname>
<given-names>WY-M</given-names>
</name>
</person-group>
<article-title>Signaling pathway participates in valproic acid-induced neuronal differentiation of neural stem cells</article-title>
<source/>Int J Clin Exp Pathol
          <year>2015</year>
<volume>8</volume>
<fpage>578</fpage>
<lpage>585</lpage>
<pub-id pub-id-type="pmid">25755748</pub-id>
</element-citation>
</ref>
<ref id="CR91">
<label>91.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qin</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Dai</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>Y</given-names>
</name>
</person-group>
<article-title>Valproic acid exposure sequentially activates Wnt and mTOR pathways in rats</article-title>
<source/>Mol Cell Neurosci
          <year>2016</year>
<volume>75</volume>
<fpage>27</fpage>
<lpage>35</lpage>
<pub-id pub-id-type="pmid">27343825</pub-id>
</element-citation>
</ref>
<ref id="CR92">
<label>92.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Christensen</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Grønborg</surname>
<given-names>TK</given-names>
</name>
<name>
<surname>Sørensen</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Schendel</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Parner</surname>
<given-names>ET</given-names>
</name>
<name>
<surname>Pedersen</surname>
<given-names>LH</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Prenatal valproate exposure and risk of autism spectrum disorders and childhood autism</article-title>
<source/>JAMA
          <year>2013</year>
<volume>309</volume>
<fpage>1696</fpage>
<lpage>1703</lpage>
<pub-id pub-id-type="pmid">23613074</pub-id>
</element-citation>
</ref>
<ref id="CR93">
<label>93.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Roche</surname>
<given-names>TE</given-names>
</name>
<name>
<surname>Baker</surname>
<given-names>JC</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Hiromasa</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Gong</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>T</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Distinct regulatory properties of pyruvate dehydrogenase kinase and phosphatase isoforms</article-title>
<source/>Prog Nucleic Acid Res Mol Biol
          <year>2001</year>
<volume>70</volume>
<fpage>33</fpage>
<lpage>75</lpage>
<pub-id pub-id-type="pmid">11642366</pub-id>
</element-citation>
</ref>
<ref id="CR94">
<label>94.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Hulver</surname>
<given-names>MW</given-names>
</name>
<name>
<surname>McMillan</surname>
<given-names>RP</given-names>
</name>
<name>
<surname>Cline</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Gilbert</surname>
<given-names>ER</given-names>
</name>
</person-group>
<article-title>The pivotal role of pyruvate dehydrogenase kinases in metabolic flexibility</article-title>
<source/>Nutr Metab
          <year>2014</year>
<volume>11</volume>
<fpage>10</fpage>
</element-citation>
</ref>
<ref id="CR95">
<label>95.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lee</surname>
<given-names>I-K</given-names>
</name>
</person-group>
<article-title>The role of pyruvate dehydrogenase kinase in diabetes and obesity</article-title>
<source/>Diabetes Metab J
          <year>2014</year>
<volume>38</volume>
<fpage>181</fpage>
<lpage>186</lpage>
<pub-id pub-id-type="pmid">25003070</pub-id>
</element-citation>
</ref>
<ref id="CR96">
<label>96.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Thompson</surname>
<given-names>CB</given-names>
</name>
</person-group>
<article-title>Wnt meets Warburg: another piece in the puzzle?</article-title>
<source/>EMBO J
          <year>2014</year>
<volume>33</volume>
<fpage>1420</fpage>
<lpage>1422</lpage>
<pub-id pub-id-type="pmid">24843042</pub-id>
</element-citation>
</ref>
<ref id="CR97">
<label>97.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lecarpentier</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Claes</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Vallée</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Hébert</surname>
<given-names>J-L</given-names>
</name>
</person-group>
<article-title>Thermodynamics in cancers: opposing interactions between PPAR gamma and the canonical WNT/beta-catenin pathway</article-title>
<source/>Clin Transl Med
          <year>2017</year>
<volume>6</volume>
<fpage>14</fpage>
<pub-id pub-id-type="pmid">28405929</pub-id>
</element-citation>
</ref>
<ref id="CR98">
<label>98.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Reuter</surname>
<given-names>S</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>SC</given-names>
</name>
<name>
<surname>Chaturvedi</surname>
<given-names>MM</given-names>
</name>
<name>
<surname>Aggarwal</surname>
<given-names>BB</given-names>
</name>
</person-group>
<article-title>Oxidative stress, inflammation, and cancer: how are they linked?</article-title>
<source/>Free Radic Biol Med
          <year>2010</year>
<volume>49</volume>
<fpage>1603</fpage>
<lpage>1616</lpage>
<pub-id pub-id-type="pmid">20840865</pub-id>
</element-citation>
</ref>
<ref id="CR99">
<label>99.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sun</surname>
<given-names>Q</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Ma</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Zha</surname>
<given-names>X</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2011</year>
<volume>108</volume>
<fpage>4129</fpage>
<lpage>4134</lpage>
<pub-id pub-id-type="pmid">21325052</pub-id>
</element-citation>
</ref>
<ref id="CR100">
<label>100.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Semenza</surname>
<given-names>GL</given-names>
</name>
</person-group>
<article-title>HIF-1: upstream and downstream of cancer metabolism</article-title>
<source/>Curr Opin Genet Dev
          <year>2010</year>
<volume>20</volume>
<fpage>51</fpage>
<lpage>56</lpage>
<pub-id pub-id-type="pmid">19942427</pub-id>
</element-citation>
</ref>
<ref id="CR101">
<label>101.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>McEwen</surname>
<given-names>BS</given-names>
</name>
<name>
<surname>Reagan</surname>
<given-names>LP</given-names>
</name>
</person-group>
<article-title>Glucose transporter expression in the central nervous system: relationship to synaptic function</article-title>
<source/>Eur J Pharmacol
          <year>2004</year>
<volume>490</volume>
<fpage>13</fpage>
<lpage>24</lpage>
<pub-id pub-id-type="pmid">15094070</pub-id>
</element-citation>
</ref>
<ref id="CR102">
<label>102.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Christofk</surname>
<given-names>HR</given-names>
</name>
<name>
<surname>Vander Heiden</surname>
<given-names>MG</given-names>
</name>
<name>
<surname>Harris</surname>
<given-names>MH</given-names>
</name>
<name>
<surname>Ramanathan</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Gerszten</surname>
<given-names>RE</given-names>
</name>
<name>
<surname>Wei</surname>
<given-names>R</given-names>
</name>
<etal></etal>
</person-group>
<article-title>The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth</article-title>
<source/>Nature
          <year>2008</year>
<volume>452</volume>
<fpage>230</fpage>
<lpage>233</lpage>
<pub-id pub-id-type="pmid">18337823</pub-id>
</element-citation>
</ref>
<ref id="CR103">
<label>103.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Harris</surname>
<given-names>RA</given-names>
</name>
<name>
<surname>Tindale</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Cumming</surname>
<given-names>RC</given-names>
</name>
</person-group>
<article-title>Age-dependent metabolic dysregulation in cancer and Alzheimer’s disease</article-title>
<source/>Biogerontology
          <year>2014</year>
<volume>15</volume>
<fpage>559</fpage>
<lpage>577</lpage>
<pub-id pub-id-type="pmid">25305052</pub-id>
</element-citation>
</ref>
<ref id="CR104">
<label>104.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lv</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Chu</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Acetylation targets the M2 isoform of pyruvate kinase for degradation through chaperone-mediated autophagy and promotes tumor growth</article-title>
<source/>Mol Cell
          <year>2011</year>
<volume>42</volume>
<fpage>719</fpage>
<lpage>730</lpage>
<pub-id pub-id-type="pmid">21700219</pub-id>
</element-citation>
</ref>
<ref id="CR105">
<label>105.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>W</given-names>
</name>
<name>
<surname>Xia</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Hawke</surname>
<given-names>D</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Liang</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Xing</surname>
<given-names>D</given-names>
</name>
<etal></etal>
</person-group>
<article-title>PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis</article-title>
<source/>Cell
          <year>2012</year>
<volume>150</volume>
<fpage>685</fpage>
<lpage>696</lpage>
<pub-id pub-id-type="pmid">22901803</pub-id>
</element-citation>
</ref>
<ref id="CR106">
<label>106.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wise</surname>
<given-names>DR</given-names>
</name>
<name>
<surname>DeBerardinis</surname>
<given-names>RJ</given-names>
</name>
<name>
<surname>Mancuso</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sayed</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>X-Y</given-names>
</name>
<name>
<surname>Pfeiffer</surname>
<given-names>HK</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction</article-title>
<source/>Proc Natl Acad Sci U S A
          <year>2008</year>
<volume>105</volume>
<fpage>18782</fpage>
<lpage>18787</lpage>
<pub-id pub-id-type="pmid">19033189</pub-id>
</element-citation>
</ref>
<ref id="CR107">
<label>107.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>J</given-names>
</name>
<name>
<surname>Gao</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y-C</given-names>
</name>
<name>
<surname>Semenza</surname>
<given-names>GL</given-names>
</name>
<name>
<surname>Dang</surname>
<given-names>CV</given-names>
</name>
</person-group>
<article-title>Hypoxia-inducible factor 1 and dysregulated c-Myc cooperatively induce vascular endothelial growth factor and metabolic switches hexokinase 2 and pyruvate dehydrogenase kinase 1</article-title>
<source/>Mol Cell Biol
          <year>2007</year>
<volume>27</volume>
<fpage>7381</fpage>
<lpage>7393</lpage>
<pub-id pub-id-type="pmid">17785433</pub-id>
</element-citation>
</ref>
<ref id="CR108">
<label>108.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moreno</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Borjas</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Arrieta</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Sáez</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Prassad</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Estévez</surname>
<given-names>J</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Clinical heterogeneity of the autistic syndrome: a study of 60 families</article-title>
<source/>Investig Clin
          <year>1992</year>
<volume>33</volume>
<fpage>13</fpage>
<lpage>31</lpage>
<pub-id pub-id-type="pmid">1391074</pub-id>
</element-citation>
</ref>
<ref id="CR109">
<label>109.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Oliveira</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Diogo</surname>
<given-names>L</given-names>
</name>
<name>
<surname>Grazina</surname>
<given-names>M</given-names>
</name>
<name>
<surname>Garcia</surname>
<given-names>P</given-names>
</name>
<name>
<surname>Ataíde</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Marques</surname>
<given-names>C</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Mitochondrial dysfunction in autism spectrum disorders: a population-based study</article-title>
<source/>Dev Med Child Neurol
          <year>2005</year>
<volume>47</volume>
<fpage>185</fpage>
<lpage>189</lpage>
<pub-id pub-id-type="pmid">15739723</pub-id>
</element-citation>
</ref>
<ref id="CR110">
<label>110.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Germanò</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Gagliano</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Magazù</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Calarese</surname>
<given-names>T</given-names>
</name>
<name>
<surname>Calabrò</surname>
<given-names>ME</given-names>
</name>
<name>
<surname>Bonsignore</surname>
<given-names>M</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Neurobiology of autism: study of a sample of autistic children</article-title>
<source/>Minerva Pediatr
          <year>2006</year>
<volume>58</volume>
<fpage>109</fpage>
<lpage>120</lpage>
<pub-id pub-id-type="pmid">16835571</pub-id>
</element-citation>
</ref>
<ref id="CR111">
<label>111.</label>
<mixed-citation publication-type="other">Hagihara H, Catts VS, Katayama Y, Shoji H, Takagi T, Huang FL, et al. Decreased brain pH as a shared Endophenotype of psychiatric disorders. Neuropsychopharmacol. Off. Publ. Am. Coll. Neuropsychopharmacol. 2017. 10.1038/npp.2017.167.</mixed-citation>
</ref>
<ref id="CR112">
<label>112.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Marín</surname>
<given-names>O</given-names>
</name>
</person-group>
<article-title>Interneuron dysfunction in psychiatric disorders</article-title>
<source/>Nat Rev Neurosci
          <year>2012</year>
<volume>13</volume>
<fpage>107</fpage>
<lpage>120</lpage>
<pub-id pub-id-type="pmid">22251963</pub-id>
</element-citation>
</ref>
<ref id="CR113">
<label>113.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Naito</surname>
<given-names>AT</given-names>
</name>
<name>
<surname>Shiojima</surname>
<given-names>I</given-names>
</name>
<name>
<surname>Komuro</surname>
<given-names>I</given-names>
</name>
</person-group>
<article-title>Wnt signaling and aging-related heart disorders</article-title>
<source/>Circ Res
          <year>2010</year>
<volume>107</volume>
<fpage>1295</fpage>
<lpage>1303</lpage>
<pub-id pub-id-type="pmid">21106946</pub-id>
</element-citation>
</ref>
<ref id="CR114">
<label>114.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>X</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Mou</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Blankesteijn</surname>
<given-names>WM</given-names>
</name>
<name>
<surname>Hall</surname>
<given-names>JLA</given-names>
</name>
</person-group>
<article-title>Role for the beta-catenin/T-cell factor signaling cascade in vascular remodeling</article-title>
<source/>Circ Res
          <year>2002</year>
<volume>90</volume>
<fpage>340</fpage>
<lpage>347</lpage>
<pub-id pub-id-type="pmid">11861424</pub-id>
</element-citation>
</ref>
<ref id="CR115">
<label>115.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morin</surname>
<given-names>PJ</given-names>
</name>
<name>
<surname>Sparks</surname>
<given-names>AB</given-names>
</name>
<name>
<surname>Korinek</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Barker</surname>
<given-names>N</given-names>
</name>
<name>
<surname>Clevers</surname>
<given-names>H</given-names>
</name>
<name>
<surname>Vogelstein</surname>
<given-names>B</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC</article-title>
<source/>Science
          <year>1997</year>
<volume>275</volume>
<fpage>1787</fpage>
<lpage>1790</lpage>
<pub-id pub-id-type="pmid">9065402</pub-id>
</element-citation>
</ref>
<ref id="CR116">
<label>116.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lecarpentier</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Schussler</surname>
<given-names>O</given-names>
</name>
<name>
<surname>Claes</surname>
<given-names>V</given-names>
</name>
<name>
<surname>Vallée</surname>
<given-names>A</given-names>
</name>
</person-group>
<article-title>The Myofibroblast: TGFβ-1, a conductor which plays a key role in fibrosis by regulating the balance between PPARγ and the canonical WNT pathway</article-title>
<source/>Nuclear Receptor Research
          <year>2017</year>
<volume>4</volume>
<fpage>23</fpage>
</element-citation>
</ref>
<ref id="CR117">
<label>117.</label>
<mixed-citation publication-type="other">Vallée A, Lecarpentier Y, Vallée J-N. Thermodynamic aspects and reprogramming cellular energy metabolism during the fibrosis process. Int J Mol Sci. 2017;18.</mixed-citation>
</ref>
<ref id="CR118">
<label>118.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Godin</surname>
<given-names>JD</given-names>
</name>
<name>
<surname>Poizat</surname>
<given-names>G</given-names>
</name>
<name>
<surname>Hickey</surname>
<given-names>MA</given-names>
</name>
<name>
<surname>Maschat</surname>
<given-names>F</given-names>
</name>
<name>
<surname>Humbert</surname>
<given-names>S</given-names>
</name>
</person-group>
<article-title>Mutant huntingtin-impaired degradation of beta-catenin causes neurotoxicity in Huntington’s disease</article-title>
<source/>EMBO J
          <year>2010</year>
<volume>29</volume>
<fpage>2433</fpage>
<lpage>2445</lpage>
<pub-id pub-id-type="pmid">20531388</pub-id>
</element-citation>
</ref>
<ref id="CR119">
<label>119.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Vallée</surname>
<given-names>A</given-names>
</name>
<name>
<surname>Lecarpentier</surname>
<given-names>Y</given-names>
</name>
<name>
<surname>Guillevin</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Vallée</surname>
<given-names>J-N</given-names>
</name>
</person-group>
<article-title>Interactions between TGF-β1, canonical WNT/β-catenin pathway and PPAR γ in radiation-induced fibrosis</article-title>
<source/>Oncotarget
          <year>2017</year>
<volume>8</volume>
<fpage>90579</fpage>
<lpage>90604</lpage>
<pub-id pub-id-type="pmid">29163854</pub-id>
</element-citation>
</ref>
<ref id="CR120">
<label>120.</label>
<mixed-citation publication-type="other">Vallée A, Lecarpentier Y, Guillevin R, Vallée J-N. Reprogramming energetic metabolism in Alzheimer’s disease. Life Sci. 2017. 10.1016/j.lfs.2017.10.033.</mixed-citation>
</ref>
<ref id="CR121">
<label>121.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Garcia-Gras</surname>
<given-names>E</given-names>
</name>
<name>
<surname>Lombardi</surname>
<given-names>R</given-names>
</name>
<name>
<surname>Giocondo</surname>
<given-names>MJ</given-names>
</name>
<name>
<surname>Willerson</surname>
<given-names>JT</given-names>
</name>
<name>
<surname>Schneider</surname>
<given-names>MD</given-names>
</name>
<name>
<surname>Khoury</surname>
<given-names>DS</given-names>
</name>
<etal></etal>
</person-group>
<article-title>Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy</article-title>
<source/>J Clin Invest
          <year>2006</year>
<volume>116</volume>
<fpage>2012</fpage>
<lpage>2021</lpage>
<pub-id pub-id-type="pmid">16823493</pub-id>
</element-citation>
</ref>
<ref id="CR122">
<label>122.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Valvezan</surname>
<given-names>AJ</given-names>
</name>
<name>
<surname>Klein</surname>
<given-names>PS</given-names>
</name>
</person-group>
<article-title>GSK-3 and Wnt signaling in neurogenesis and bipolar disorder</article-title>
<source/>Front Mol Neurosci
          <year>2012</year>
<volume>5</volume>
<fpage>1</fpage>
<pub-id pub-id-type="pmid">22319467</pub-id>
</element-citation>
</ref>
<ref id="CR123">
<label>123.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Canalis</surname>
<given-names>E</given-names>
</name>
</person-group>
<article-title>Wnt signalling in osteoporosis: mechanisms and novel therapeutic approaches</article-title>
<source/>Nat Rev Endocrinol
          <year>2013</year>
<volume>9</volume>
<fpage>575</fpage>
<lpage>583</lpage>
<pub-id pub-id-type="pmid">23938284</pub-id>
</element-citation>
</ref>
<ref id="CR124">
<label>124.</label>
<element-citation publication-type="journal">
<person-group person-group-type="author">
<name>
<surname>Berwick</surname>
<given-names>DC</given-names>
</name>
<name>
<surname>Harvey</surname>
<given-names>K</given-names>
</name>
</person-group>
<article-title>The importance of Wnt signalling for neurodegeneration in Parkinson’s disease</article-title>
<source/>Biochem Soc Trans
          <year>2012</year>
<volume>40</volume>
<fpage>1123</fpage>
<lpage>1128</lpage>
<pub-id pub-id-type="pmid">22988876</pub-id>
</element-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>